
CIMZIA® (certolizumab pegol) | An FDA-Approved Biologic …
See the booklet called “Instructions for Use” packaged in your CIMZIA prefilled syringe kit on how to inject CIMZIA the right way. Do not give yourself an injection of CIMZIA unless you have …
CIMZIA® Injection Instructions | Self-Inject with the prefilled syringe
You or a caregiver will need to receive training at the doctor’s office on how to inject CIMZIA. This can feel like a big step, but breathe—you’ve got this! If you ever need a refresher, we’ve got …
How CIMZIA® Works for Moderate-to-Severe Rheumatoid Arthritis
Hear from real patients about their experience with CIMZIA, learn more about what to expect from treating your rheumatoid arthritis (RA) at home, or get familiar with how to self-administer …
Dosing and Administration | CIMZIA® (certolizumab pegol)
Learn how to take CIMZIA® including dosage and administration schedule. See full Prescribing Information including boxed warning on serious infections.
CIMZIA® CIMplicity® Savings Program
Eligible, commercially insured patients with approved coverage may receive CIMZIA® for as little as $0 per dose. See full PI including boxed warning.
CIMZIA® for Moderate-to-Severe Rheumatoid Arthritis
CIMZIA® (certolizumab pegol) is a treatment for rheumatoid arthritis. See full Prescribing Information including boxed warning on serious infections.
What is CIMZIA? CIMZIA is a prescription medicine called a Tumor Necrosis Factor (TNF) blocker used in adults to:
CIMZIA® CIMplicity Savings Program and Support
CIMZIA is a prescription medicine called a Tumor Necrosis Factor (TNF) blocker used to: Lessen the signs and symptoms of moderately to severely active Crohn’s disease (CD) in adults who …
CIMplicity® Registration | CIMZIA®
See the booklet called “Instructions for Use” packaged in your CIMZIA prefilled syringe kit on how to inject CIMZIA the right way. Do not give yourself an injection of CIMZIA unless you have …
Patients receiving CIMZIA 400 mg as monotherapy every 4 weeks in rheumatoid arthritis controlled clinical trials had similar adverse reactions to those patients receiving CIMZIA 200 …